Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™

NCT02937740 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism

Interventions

DRUG: NATESTO Testosterone Nasal Gel

Sponsor

Acerus Pharmaceuticals Corporation